1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPhase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes is sponsored by European Commission — Horizon Europe. Programme areas: Health, Global Challenges and European Industrial Competitiveness, Horizon Europe (HORIZON)
Get alerted about grants like this
Save a search for “European Commission — Horizon Europe” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Open to legal entities established in EU Member States and countries associated to Horizon Europe (including EEA/EFTA countries, and other associated third countries). Action type: HORIZON-RIA. See the official call documentation on the F&T Portal for full eligibility criteria and participation rules. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Funding amounts vary based on project scope and sponsor guidance. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is September 21, 2027. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) is a grant from the National Institutes of Health (NIH) that funds the development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. As part of NIH's INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE), the award supports up to two years of R61 preliminary/planning studies, with possible transition to three years of R33 clinical trial support, for a maximum of five years. Applications are due July 1, 2026. Eligible applicants include nonprofits, universities, for-profit organizations, and state and local governments.
USDA SBIR Phase I – AgTech (including precision farming, drone‑based technologies) is sponsored by USDA National Institute of Food and Agriculture (USDA‑NIFA). USDA SBIR Phase I – AgTech is a grant from USDA National Institute of Food and Agriculture (USDA-NIFA) that funds early-stage research and development in agricultural technology, including precision farming, drone-based technologies, and other innovations that strengthen U.